Skadden Reps JLL Partners In $115M Health Buy-And-Build
JLL Partners, a New York-based private equity firm with about $4 billion of capital and a focus on healthcare and pharma deals, will pay Pennsylvania-based BioClinica stockholders $7.25 per share. The tender offer follows a merger agreement signed Jan. 30.
JLL is also acquiring CoreLab Partners Inc., a...
To view the full article, register now.